Urothelial Carcinoma Treatment Market - Top Companies and Manufacturers

In the News

• Olympus Corporation announced a binding agreement to purchase London-based cloud-AI endoscopy business Odin Vision, which offers a wide range of commercially available computer-aided detection/diagnostic (CAD) solutions. With the agreement, Olympus is able to provide cutting-edge AI-powered solutions and data-driven insights that improve clinical and procedural procedures and change patient care.

• Sanofi SA licensed an NK cell engager program from Innate's ANKETTM (Antibody-based NK Cell Engager Therapies) technology that targets B₇H₃. This extended partnership with Innate Pharma will enable Sanofi to have the option of including up to two more ANKETTM targets, and be in control of all development, manufacture, and marketing.